Valuation: MRI Interventions Inc

Market Cap 52Cr 44Cr 42Cr 38Cr 72Cr 4.93TCr 72Cr 489.99Cr 190.75Cr 2.49TCr 194.26Cr 190.02Cr 8.24TCr P/E 2026 *
-12.8x
P/E 2027 * -15.3x
Enterprise Value 52Cr 44Cr 42Cr 38Cr 72Cr 4.93TCr 72Cr 489.99Cr 190.75Cr 2.49TCr 194.26Cr 190.02Cr 8.24TCr EV / Sales 2026 *
10.6x
EV / Sales 2027 * 9.07x
Free-Float
94.56%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 49 07/11/2017
Director of Finance/CFO 41 01/01/2021
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 68 10/03/2014
Chairman 80 04/02/2021
Director/Board Member 49 07/11/2017
Change 5-day change 1-year change 3-year change Capi.($)
+24.88%-8.05% - - 52Cr
+0.60%+2.88%+29.22%+15.77% 23TCr
-0.06%+1.97%+4.56%-17.53% 15TCr
-0.85%-7.37%-22.32%+22.20% 13TCr
-4.55%-8.50%-55.27%-11.53% 7.23TCr
-0.62%-1.23%-16.41%-13.68% 5.16TCr
-0.01%-1.58%+11.75%+19.45% 5.24TCr
-0.83%-1.27%+29.70%+27.95% 4.37TCr
+0.26%+0.12%+40.58%+47.92% 4.07TCr
+0.11%+10.24%+128.90%+42.85% 3.4TCr
Average +1.90%+3.90%+16.75%+14.82% 9TCr
Weighted average by Cap. -0.43%+3.71%+9.45%+9.91%

Financials

2026 *2027 *
Net sales 4.89Cr 4.19Cr 3.93Cr 3.59Cr 6.77Cr 466.19Cr 6.84Cr 46Cr 18Cr 235.2Cr 18Cr 18Cr 778.91Cr 5.71Cr 4.89Cr 4.58Cr 4.19Cr 7.9Cr 544.04Cr 7.98Cr 54Cr 21Cr 274.48Cr 21Cr 21Cr 908.99Cr
Net income -4Cr -3.42Cr -3.21Cr -2.93Cr -5.53Cr -381.02Cr -5.59Cr -38Cr -15Cr -192.23Cr -15Cr -15Cr -636.61Cr -3.52Cr -3.02Cr -2.83Cr -2.58Cr -4.88Cr -335.9Cr -4.92Cr -33Cr -13Cr -169.47Cr -13Cr -13Cr -561.22Cr
Net Debt - -
Logo MRI Interventions Inc
ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-